nodes	percent_of_prediction	percent_of_DWPC	metapath
Bumetanide—SLCO1A2—Prednisone—systemic scleroderma	0.12	0.214	CbGbCtD
Bumetanide—SLC22A6—Captopril—systemic scleroderma	0.116	0.206	CbGbCtD
Bumetanide—SLC22A11—Methotrexate—systemic scleroderma	0.0902	0.161	CbGbCtD
Bumetanide—SLC22A7—Methotrexate—systemic scleroderma	0.0859	0.153	CbGbCtD
Bumetanide—CA5B—cervicothoracic ganglion—systemic scleroderma	0.0644	0.47	CbGeAlD
Bumetanide—SLCO1A2—Methotrexate—systemic scleroderma	0.0602	0.107	CbGbCtD
Bumetanide—SLC22A8—Methotrexate—systemic scleroderma	0.0524	0.0935	CbGbCtD
Bumetanide—SLC22A6—Methotrexate—systemic scleroderma	0.0365	0.0651	CbGbCtD
Bumetanide—PTGS2—skeletal joint—systemic scleroderma	0.00663	0.0484	CbGeAlD
Bumetanide—SLC12A4—lung—systemic scleroderma	0.00351	0.0256	CbGeAlD
Bumetanide—CFTR—digestive system—systemic scleroderma	0.0033	0.0241	CbGeAlD
Bumetanide—PTGS2—Fluocinonide—Mometasone—systemic scleroderma	0.0033	0.624	CbGdCrCtD
Bumetanide—CA7—digestive system—systemic scleroderma	0.00325	0.0237	CbGeAlD
Bumetanide—CA12—connective tissue—systemic scleroderma	0.00292	0.0214	CbGeAlD
Bumetanide—SLC12A2—digestive system—systemic scleroderma	0.0029	0.0212	CbGeAlD
Bumetanide—CA9—digestive system—systemic scleroderma	0.00286	0.0209	CbGeAlD
Bumetanide—PTGS2—artery—systemic scleroderma	0.00278	0.0203	CbGeAlD
Bumetanide—SLC12A2—tendon—systemic scleroderma	0.00276	0.0202	CbGeAlD
Bumetanide—CFTR—lung—systemic scleroderma	0.00276	0.0201	CbGeAlD
Bumetanide—SLC10A1—digestive system—systemic scleroderma	0.00274	0.02	CbGeAlD
Bumetanide—CA9—tendon—systemic scleroderma	0.00272	0.0198	CbGeAlD
Bumetanide—CA14—tendon—systemic scleroderma	0.00258	0.0188	CbGeAlD
Bumetanide—SLC22A11—digestive system—systemic scleroderma	0.0025	0.0183	CbGeAlD
Bumetanide—SLC22A7—digestive system—systemic scleroderma	0.00244	0.0178	CbGeAlD
Bumetanide—SLC12A2—lung—systemic scleroderma	0.00242	0.0177	CbGeAlD
Bumetanide—PTGS2—endothelium—systemic scleroderma	0.00234	0.0171	CbGeAlD
Bumetanide—PTGS2—blood vessel—systemic scleroderma	0.00216	0.0158	CbGeAlD
Bumetanide—CA12—digestive system—systemic scleroderma	0.00211	0.0154	CbGeAlD
Bumetanide—PTGS2—Fluticasone Propionate—Mometasone—systemic scleroderma	0.00199	0.376	CbGdCrCtD
Bumetanide—CA5B—tendon—systemic scleroderma	0.0018	0.0132	CbGeAlD
Bumetanide—CA12—lung—systemic scleroderma	0.00176	0.0129	CbGeAlD
Bumetanide—Azotaemia—Methotrexate—systemic scleroderma	0.00175	0.00589	CcSEcCtD
Bumetanide—Blood uric acid increased—Mycophenolate mofetil—systemic scleroderma	0.00167	0.00564	CcSEcCtD
Bumetanide—Hepatocellular injury—Mycophenolate mofetil—systemic scleroderma	0.00164	0.00554	CcSEcCtD
Bumetanide—Pancreatitis—Captopril—systemic scleroderma	0.00163	0.00549	CcSEcCtD
Bumetanide—CA5B—lung—systemic scleroderma	0.00158	0.0116	CbGeAlD
Bumetanide—Hyponatraemia—Mycophenolic acid—systemic scleroderma	0.00152	0.00512	CcSEcCtD
Bumetanide—Toxic epidermal necrolysis—Azathioprine—systemic scleroderma	0.00151	0.00509	CcSEcCtD
Bumetanide—SLCO1A2—digestive system—systemic scleroderma	0.00148	0.0108	CbGeAlD
Bumetanide—Gynaecomastia—Mycophenolate mofetil—systemic scleroderma	0.00147	0.00496	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Captopril—systemic scleroderma	0.00147	0.00495	CcSEcCtD
Bumetanide—Muscle spasms—Pentoxifylline—systemic scleroderma	0.00147	0.00495	CcSEcCtD
Bumetanide—Renal failure—Captopril—systemic scleroderma	0.00146	0.00491	CcSEcCtD
Bumetanide—Encephalopathy—Methotrexate—systemic scleroderma	0.00145	0.00489	CcSEcCtD
Bumetanide—Hypokalaemia—Leflunomide—systemic scleroderma	0.00144	0.00486	CcSEcCtD
Bumetanide—Cramp muscle—Leflunomide—systemic scleroderma	0.00143	0.00481	CcSEcCtD
Bumetanide—Toxic epidermal necrolysis—Leflunomide—systemic scleroderma	0.00143	0.00481	CcSEcCtD
Bumetanide—Pancreatitis—Azathioprine—systemic scleroderma	0.00142	0.00479	CcSEcCtD
Bumetanide—Blood creatinine increased—Mycophenolic acid—systemic scleroderma	0.00142	0.00477	CcSEcCtD
Bumetanide—Dehydration—Mycophenolic acid—systemic scleroderma	0.00141	0.00474	CcSEcCtD
Bumetanide—Abdominal discomfort—Azathioprine—systemic scleroderma	0.00139	0.00469	CcSEcCtD
Bumetanide—Hypokalaemia—Mycophenolic acid—systemic scleroderma	0.00138	0.00464	CcSEcCtD
Bumetanide—Glycosuria—Prednisone—systemic scleroderma	0.00138	0.00464	CcSEcCtD
Bumetanide—Leukopenia—Pentoxifylline—systemic scleroderma	0.00137	0.00461	CcSEcCtD
Bumetanide—Hyponatraemia—Lisinopril—systemic scleroderma	0.00137	0.00461	CcSEcCtD
Bumetanide—Cramp muscle—Mycophenolic acid—systemic scleroderma	0.00136	0.00459	CcSEcCtD
Bumetanide—Pancreatitis—Leflunomide—systemic scleroderma	0.00134	0.00453	CcSEcCtD
Bumetanide—CA4—digestive system—systemic scleroderma	0.00131	0.00955	CbGeAlD
Bumetanide—Chest pain—Pentoxifylline—systemic scleroderma	0.0013	0.00438	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Azathioprine—systemic scleroderma	0.00128	0.00432	CcSEcCtD
Bumetanide—Pancreatitis—Mycophenolic acid—systemic scleroderma	0.00128	0.00432	CcSEcCtD
Bumetanide—Blood creatinine increased—Lisinopril—systemic scleroderma	0.00128	0.0043	CcSEcCtD
Bumetanide—Dry mouth—Pentoxifylline—systemic scleroderma	0.00127	0.00429	CcSEcCtD
Bumetanide—Dehydration—Lisinopril—systemic scleroderma	0.00127	0.00427	CcSEcCtD
Bumetanide—Erythema multiforme—Captopril—systemic scleroderma	0.00126	0.00424	CcSEcCtD
Bumetanide—CA4—tendon—systemic scleroderma	0.00124	0.00909	CbGeAlD
Bumetanide—Hyperglycaemia—Leflunomide—systemic scleroderma	0.00124	0.00416	CcSEcCtD
Bumetanide—SLCO1A2—lung—systemic scleroderma	0.00123	0.00902	CbGeAlD
Bumetanide—Toxic epidermal necrolysis—Lisinopril—systemic scleroderma	0.00123	0.00413	CcSEcCtD
Bumetanide—Cramp muscle—Lisinopril—systemic scleroderma	0.00123	0.00413	CcSEcCtD
Bumetanide—Thrombocytopenia—Pentoxifylline—systemic scleroderma	0.00122	0.00412	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Leflunomide—systemic scleroderma	0.00121	0.00408	CcSEcCtD
Bumetanide—Hyperhidrosis—Pentoxifylline—systemic scleroderma	0.00121	0.00406	CcSEcCtD
Bumetanide—Renal failure—Leflunomide—systemic scleroderma	0.0012	0.00405	CcSEcCtD
Bumetanide—Hyponatraemia—Mycophenolate mofetil—systemic scleroderma	0.0012	0.00404	CcSEcCtD
Bumetanide—Hyperglycaemia—Mycophenolic acid—systemic scleroderma	0.00118	0.00397	CcSEcCtD
Bumetanide—Hypotension—Pentoxifylline—systemic scleroderma	0.00117	0.00393	CcSEcCtD
Bumetanide—Pancreatitis—Lisinopril—systemic scleroderma	0.00115	0.00389	CcSEcCtD
Bumetanide—Renal failure—Mycophenolic acid—systemic scleroderma	0.00115	0.00386	CcSEcCtD
Bumetanide—Arthralgia—Mometasone—systemic scleroderma	0.00112	0.00378	CcSEcCtD
Bumetanide—Chest pain—Mometasone—systemic scleroderma	0.00112	0.00378	CcSEcCtD
Bumetanide—Blood creatinine increased—Mycophenolate mofetil—systemic scleroderma	0.00112	0.00377	CcSEcCtD
Bumetanide—Sweating—Mycophenolic acid—systemic scleroderma	0.00112	0.00376	CcSEcCtD
Bumetanide—Dehydration—Mycophenolate mofetil—systemic scleroderma	0.00111	0.00374	CcSEcCtD
Bumetanide—PTGS2—connective tissue—systemic scleroderma	0.00111	0.0081	CbGeAlD
Bumetanide—Dry mouth—Mometasone—systemic scleroderma	0.0011	0.0037	CcSEcCtD
Bumetanide—Erythema multiforme—Azathioprine—systemic scleroderma	0.0011	0.0037	CcSEcCtD
Bumetanide—CA4—lung—systemic scleroderma	0.00109	0.00798	CbGeAlD
Bumetanide—Hypokalaemia—Mycophenolate mofetil—systemic scleroderma	0.00109	0.00366	CcSEcCtD
Bumetanide—Hyperglycaemia—Lisinopril—systemic scleroderma	0.00106	0.00358	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Lisinopril—systemic scleroderma	0.00104	0.00351	CcSEcCtD
Bumetanide—Erythema multiforme—Leflunomide—systemic scleroderma	0.00104	0.00349	CcSEcCtD
Bumetanide—Renal failure—Lisinopril—systemic scleroderma	0.00103	0.00348	CcSEcCtD
Bumetanide—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.00102	0.00344	CcSEcCtD
Bumetanide—PTGS2—smooth muscle tissue—systemic scleroderma	0.00101	0.00741	CbGeAlD
Bumetanide—Pancreatitis—Mycophenolate mofetil—systemic scleroderma	0.00101	0.00341	CcSEcCtD
Bumetanide—Sweating—Lisinopril—systemic scleroderma	0.00101	0.00339	CcSEcCtD
Bumetanide—Hyperuricaemia—Methotrexate—systemic scleroderma	0.001	0.00338	CcSEcCtD
Bumetanide—PTGS2—skin of body—systemic scleroderma	0.001	0.00731	CbGeAlD
Bumetanide—Urticaria—Pentoxifylline—systemic scleroderma	0.000991	0.00334	CcSEcCtD
Bumetanide—Arthralgia—Captopril—systemic scleroderma	0.000986	0.00332	CcSEcCtD
Bumetanide—Chest pain—Captopril—systemic scleroderma	0.000986	0.00332	CcSEcCtD
Bumetanide—Abdominal pain—Pentoxifylline—systemic scleroderma	0.000986	0.00332	CcSEcCtD
Bumetanide—Dry mouth—Captopril—systemic scleroderma	0.000965	0.00325	CcSEcCtD
Bumetanide—Blood uric acid increased—Methotrexate—systemic scleroderma	0.000949	0.0032	CcSEcCtD
Bumetanide—Hyperglycaemia—Mycophenolate mofetil—systemic scleroderma	0.000931	0.00314	CcSEcCtD
Bumetanide—Fatigue—Mometasone—systemic scleroderma	0.000928	0.00313	CcSEcCtD
Bumetanide—Thrombocytopenia—Captopril—systemic scleroderma	0.000926	0.00312	CcSEcCtD
Bumetanide—Muscle spasms—Leflunomide—systemic scleroderma	0.000918	0.00309	CcSEcCtD
Bumetanide—Leukopenia—Azathioprine—systemic scleroderma	0.000905	0.00305	CcSEcCtD
Bumetanide—Renal failure—Mycophenolate mofetil—systemic scleroderma	0.000904	0.00305	CcSEcCtD
Bumetanide—Asthenia—Pentoxifylline—systemic scleroderma	0.000895	0.00302	CcSEcCtD
Bumetanide—Erythema multiforme—Lisinopril—systemic scleroderma	0.000891	0.003	CcSEcCtD
Bumetanide—Hypotension—Captopril—systemic scleroderma	0.000883	0.00298	CcSEcCtD
Bumetanide—Pruritus—Pentoxifylline—systemic scleroderma	0.000883	0.00297	CcSEcCtD
Bumetanide—Sweating—Mycophenolate mofetil—systemic scleroderma	0.000882	0.00297	CcSEcCtD
Bumetanide—Gastrointestinal pain—Mometasone—systemic scleroderma	0.00088	0.00297	CcSEcCtD
Bumetanide—Muscle spasms—Mycophenolic acid—systemic scleroderma	0.000876	0.00295	CcSEcCtD
Bumetanide—Arthralgia—Azathioprine—systemic scleroderma	0.000861	0.0029	CcSEcCtD
Bumetanide—Vertigo—Leflunomide—systemic scleroderma	0.000858	0.00289	CcSEcCtD
Bumetanide—Leukopenia—Leflunomide—systemic scleroderma	0.000855	0.00288	CcSEcCtD
Bumetanide—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000854	0.00288	CcSEcCtD
Bumetanide—Abdominal pain—Mometasone—systemic scleroderma	0.000851	0.00287	CcSEcCtD
Bumetanide—Gynaecomastia—Methotrexate—systemic scleroderma	0.000833	0.00281	CcSEcCtD
Bumetanide—Dizziness—Pentoxifylline—systemic scleroderma	0.000825	0.00278	CcSEcCtD
Bumetanide—Vertigo—Mycophenolic acid—systemic scleroderma	0.000818	0.00276	CcSEcCtD
Bumetanide—Leukopenia—Mycophenolic acid—systemic scleroderma	0.000815	0.00275	CcSEcCtD
Bumetanide—Fatigue—Captopril—systemic scleroderma	0.000815	0.00275	CcSEcCtD
Bumetanide—Arthralgia—Leflunomide—systemic scleroderma	0.000813	0.00274	CcSEcCtD
Bumetanide—Chest pain—Leflunomide—systemic scleroderma	0.000813	0.00274	CcSEcCtD
Bumetanide—Thrombocytopenia—Azathioprine—systemic scleroderma	0.000808	0.00272	CcSEcCtD
Bumetanide—PTGS2—digestive system—systemic scleroderma	0.000801	0.00585	CbGeAlD
Bumetanide—Dry mouth—Leflunomide—systemic scleroderma	0.000795	0.00268	CcSEcCtD
Bumetanide—Vomiting—Pentoxifylline—systemic scleroderma	0.000793	0.00267	CcSEcCtD
Bumetanide—Muscle spasms—Lisinopril—systemic scleroderma	0.000789	0.00266	CcSEcCtD
Bumetanide—Rash—Pentoxifylline—systemic scleroderma	0.000787	0.00265	CcSEcCtD
Bumetanide—Dermatitis—Pentoxifylline—systemic scleroderma	0.000786	0.00265	CcSEcCtD
Bumetanide—Headache—Pentoxifylline—systemic scleroderma	0.000782	0.00263	CcSEcCtD
Bumetanide—Chest pain—Mycophenolic acid—systemic scleroderma	0.000775	0.00261	CcSEcCtD
Bumetanide—Arthralgia—Mycophenolic acid—systemic scleroderma	0.000775	0.00261	CcSEcCtD
Bumetanide—Gastrointestinal pain—Captopril—systemic scleroderma	0.000773	0.0026	CcSEcCtD
Bumetanide—Asthenia—Mometasone—systemic scleroderma	0.000772	0.0026	CcSEcCtD
Bumetanide—Hypotension—Azathioprine—systemic scleroderma	0.000771	0.0026	CcSEcCtD
Bumetanide—Polyuria—Methotrexate—systemic scleroderma	0.00077	0.00259	CcSEcCtD
Bumetanide—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000763	0.00257	CcSEcCtD
Bumetanide—PTGS2—tendon—systemic scleroderma	0.000762	0.00556	CbGeAlD
Bumetanide—Pruritus—Mometasone—systemic scleroderma	0.000762	0.00257	CcSEcCtD
Bumetanide—Dry mouth—Mycophenolic acid—systemic scleroderma	0.000758	0.00256	CcSEcCtD
Bumetanide—Hyperhidrosis—Leflunomide—systemic scleroderma	0.000753	0.00254	CcSEcCtD
Bumetanide—Abdominal pain—Captopril—systemic scleroderma	0.000747	0.00252	CcSEcCtD
Bumetanide—Nausea—Pentoxifylline—systemic scleroderma	0.000741	0.0025	CcSEcCtD
Bumetanide—Vertigo—Lisinopril—systemic scleroderma	0.000737	0.00248	CcSEcCtD
Bumetanide—Diarrhoea—Mometasone—systemic scleroderma	0.000737	0.00248	CcSEcCtD
Bumetanide—Hypokalaemia—Prednisone—systemic scleroderma	0.000736	0.00248	CcSEcCtD
Bumetanide—Leukopenia—Lisinopril—systemic scleroderma	0.000734	0.00247	CcSEcCtD
Bumetanide—Hypotension—Leflunomide—systemic scleroderma	0.000728	0.00245	CcSEcCtD
Bumetanide—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000728	0.00245	CcSEcCtD
Bumetanide—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000719	0.00242	CcSEcCtD
Bumetanide—Arthralgia—Lisinopril—systemic scleroderma	0.000698	0.00235	CcSEcCtD
Bumetanide—Chest pain—Lisinopril—systemic scleroderma	0.000698	0.00235	CcSEcCtD
Bumetanide—Hypotension—Mycophenolic acid—systemic scleroderma	0.000695	0.00234	CcSEcCtD
Bumetanide—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000691	0.00233	CcSEcCtD
Bumetanide—Pancreatitis—Prednisone—systemic scleroderma	0.000686	0.00231	CcSEcCtD
Bumetanide—Vomiting—Mometasone—systemic scleroderma	0.000684	0.00231	CcSEcCtD
Bumetanide—Dry mouth—Lisinopril—systemic scleroderma	0.000683	0.0023	CcSEcCtD
Bumetanide—Rash—Mometasone—systemic scleroderma	0.000679	0.00229	CcSEcCtD
Bumetanide—Asthenia—Captopril—systemic scleroderma	0.000678	0.00229	CcSEcCtD
Bumetanide—Dermatitis—Mometasone—systemic scleroderma	0.000678	0.00228	CcSEcCtD
Bumetanide—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000675	0.00227	CcSEcCtD
Bumetanide—Headache—Mometasone—systemic scleroderma	0.000674	0.00227	CcSEcCtD
Bumetanide—Fatigue—Leflunomide—systemic scleroderma	0.000672	0.00226	CcSEcCtD
Bumetanide—Pruritus—Captopril—systemic scleroderma	0.000669	0.00225	CcSEcCtD
Bumetanide—PTGS2—lung—systemic scleroderma	0.000669	0.00488	CbGeAlD
Bumetanide—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000656	0.00221	CcSEcCtD
Bumetanide—Abdominal pain—Azathioprine—systemic scleroderma	0.000652	0.0022	CcSEcCtD
Bumetanide—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000647	0.00218	CcSEcCtD
Bumetanide—Diarrhoea—Captopril—systemic scleroderma	0.000647	0.00218	CcSEcCtD
Bumetanide—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000646	0.00218	CcSEcCtD
Bumetanide—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000643	0.00217	CcSEcCtD
Bumetanide—Fatigue—Mycophenolic acid—systemic scleroderma	0.000641	0.00216	CcSEcCtD
Bumetanide—Nausea—Mometasone—systemic scleroderma	0.000639	0.00215	CcSEcCtD
Bumetanide—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000637	0.00215	CcSEcCtD
Bumetanide—Hyperglycaemia—Prednisone—systemic scleroderma	0.000631	0.00213	CcSEcCtD
Bumetanide—Hypotension—Lisinopril—systemic scleroderma	0.000626	0.00211	CcSEcCtD
Bumetanide—Dizziness—Captopril—systemic scleroderma	0.000625	0.00211	CcSEcCtD
Bumetanide—Urticaria—Leflunomide—systemic scleroderma	0.000619	0.00209	CcSEcCtD
Bumetanide—Abdominal pain—Leflunomide—systemic scleroderma	0.000616	0.00208	CcSEcCtD
Bumetanide—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000612	0.00206	CcSEcCtD
Bumetanide—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000612	0.00206	CcSEcCtD
Bumetanide—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000609	0.00205	CcSEcCtD
Bumetanide—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000608	0.00205	CcSEcCtD
Bumetanide—Vomiting—Captopril—systemic scleroderma	0.000601	0.00203	CcSEcCtD
Bumetanide—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000599	0.00202	CcSEcCtD
Bumetanide—Rash—Captopril—systemic scleroderma	0.000596	0.00201	CcSEcCtD
Bumetanide—Dermatitis—Captopril—systemic scleroderma	0.000596	0.00201	CcSEcCtD
Bumetanide—Headache—Captopril—systemic scleroderma	0.000592	0.002	CcSEcCtD
Bumetanide—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000588	0.00198	CcSEcCtD
Bumetanide—Fatigue—Lisinopril—systemic scleroderma	0.000577	0.00194	CcSEcCtD
Bumetanide—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000574	0.00194	CcSEcCtD
Bumetanide—Pancreatitis—Methotrexate—systemic scleroderma	0.000573	0.00193	CcSEcCtD
Bumetanide—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000567	0.00191	CcSEcCtD
Bumetanide—Diarrhoea—Azathioprine—systemic scleroderma	0.000565	0.0019	CcSEcCtD
Bumetanide—Nausea—Captopril—systemic scleroderma	0.000562	0.00189	CcSEcCtD
Bumetanide—Abdominal discomfort—Methotrexate—systemic scleroderma	0.00056	0.00189	CcSEcCtD
Bumetanide—Asthenia—Leflunomide—systemic scleroderma	0.000559	0.00188	CcSEcCtD
Bumetanide—Pruritus—Leflunomide—systemic scleroderma	0.000551	0.00186	CcSEcCtD
Bumetanide—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000548	0.00185	CcSEcCtD
Bumetanide—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000548	0.00184	CcSEcCtD
Bumetanide—Dizziness—Azathioprine—systemic scleroderma	0.000546	0.00184	CcSEcCtD
Bumetanide—Asthenia—Mycophenolic acid—systemic scleroderma	0.000533	0.0018	CcSEcCtD
Bumetanide—Diarrhoea—Leflunomide—systemic scleroderma	0.000533	0.0018	CcSEcCtD
Bumetanide—Urticaria—Lisinopril—systemic scleroderma	0.000532	0.00179	CcSEcCtD
Bumetanide—Abdominal pain—Lisinopril—systemic scleroderma	0.000529	0.00178	CcSEcCtD
Bumetanide—Pruritus—Mycophenolic acid—systemic scleroderma	0.000526	0.00177	CcSEcCtD
Bumetanide—Vomiting—Azathioprine—systemic scleroderma	0.000525	0.00177	CcSEcCtD
Bumetanide—Rash—Azathioprine—systemic scleroderma	0.00052	0.00175	CcSEcCtD
Bumetanide—Dermatitis—Azathioprine—systemic scleroderma	0.00052	0.00175	CcSEcCtD
Bumetanide—Headache—Azathioprine—systemic scleroderma	0.000517	0.00174	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000517	0.00174	CcSEcCtD
Bumetanide—Dizziness—Leflunomide—systemic scleroderma	0.000515	0.00174	CcSEcCtD
Bumetanide—Renal failure—Methotrexate—systemic scleroderma	0.000512	0.00173	CcSEcCtD
Bumetanide—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000509	0.00171	CcSEcCtD
Bumetanide—Sweating—Methotrexate—systemic scleroderma	0.0005	0.00168	CcSEcCtD
Bumetanide—Vomiting—Leflunomide—systemic scleroderma	0.000495	0.00167	CcSEcCtD
Bumetanide—Dizziness—Mycophenolic acid—systemic scleroderma	0.000492	0.00166	CcSEcCtD
Bumetanide—Rash—Leflunomide—systemic scleroderma	0.000491	0.00166	CcSEcCtD
Bumetanide—Dermatitis—Leflunomide—systemic scleroderma	0.000491	0.00165	CcSEcCtD
Bumetanide—Nausea—Azathioprine—systemic scleroderma	0.00049	0.00165	CcSEcCtD
Bumetanide—Headache—Leflunomide—systemic scleroderma	0.000488	0.00164	CcSEcCtD
Bumetanide—Asthenia—Lisinopril—systemic scleroderma	0.00048	0.00162	CcSEcCtD
Bumetanide—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.00048	0.00162	CcSEcCtD
Bumetanide—Pruritus—Lisinopril—systemic scleroderma	0.000474	0.0016	CcSEcCtD
Bumetanide—Vomiting—Mycophenolic acid—systemic scleroderma	0.000473	0.00159	CcSEcCtD
Bumetanide—Rash—Mycophenolic acid—systemic scleroderma	0.000469	0.00158	CcSEcCtD
Bumetanide—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000468	0.00158	CcSEcCtD
Bumetanide—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000466	0.00157	CcSEcCtD
Bumetanide—Headache—Mycophenolic acid—systemic scleroderma	0.000466	0.00157	CcSEcCtD
Bumetanide—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000464	0.00156	CcSEcCtD
Bumetanide—Nausea—Leflunomide—systemic scleroderma	0.000463	0.00156	CcSEcCtD
Bumetanide—Diarrhoea—Lisinopril—systemic scleroderma	0.000458	0.00154	CcSEcCtD
Bumetanide—Dizziness—Lisinopril—systemic scleroderma	0.000443	0.00149	CcSEcCtD
Bumetanide—Erythema multiforme—Methotrexate—systemic scleroderma	0.000442	0.00149	CcSEcCtD
Bumetanide—Nausea—Mycophenolic acid—systemic scleroderma	0.000442	0.00149	CcSEcCtD
Bumetanide—Vertigo—Prednisone—systemic scleroderma	0.000438	0.00147	CcSEcCtD
Bumetanide—Vomiting—Lisinopril—systemic scleroderma	0.000426	0.00143	CcSEcCtD
Bumetanide—Rash—Lisinopril—systemic scleroderma	0.000422	0.00142	CcSEcCtD
Bumetanide—Dermatitis—Lisinopril—systemic scleroderma	0.000422	0.00142	CcSEcCtD
Bumetanide—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000421	0.00142	CcSEcCtD
Bumetanide—Headache—Lisinopril—systemic scleroderma	0.000419	0.00141	CcSEcCtD
Bumetanide—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000415	0.0014	CcSEcCtD
Bumetanide—Arthralgia—Prednisone—systemic scleroderma	0.000415	0.0014	CcSEcCtD
Bumetanide—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000401	0.00135	CcSEcCtD
Bumetanide—Nausea—Lisinopril—systemic scleroderma	0.000398	0.00134	CcSEcCtD
Bumetanide—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000388	0.00131	CcSEcCtD
Bumetanide—Hyperhidrosis—Prednisone—systemic scleroderma	0.000384	0.0013	CcSEcCtD
Bumetanide—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000373	0.00126	CcSEcCtD
Bumetanide—Rash—Mycophenolate mofetil—systemic scleroderma	0.00037	0.00125	CcSEcCtD
Bumetanide—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00037	0.00125	CcSEcCtD
Bumetanide—Headache—Mycophenolate mofetil—systemic scleroderma	0.000368	0.00124	CcSEcCtD
Bumetanide—Vertigo—Methotrexate—systemic scleroderma	0.000366	0.00123	CcSEcCtD
Bumetanide—Leukopenia—Methotrexate—systemic scleroderma	0.000364	0.00123	CcSEcCtD
Bumetanide—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000348	0.00117	CcSEcCtD
Bumetanide—Arthralgia—Methotrexate—systemic scleroderma	0.000347	0.00117	CcSEcCtD
Bumetanide—Chest pain—Methotrexate—systemic scleroderma	0.000347	0.00117	CcSEcCtD
Bumetanide—Fatigue—Prednisone—systemic scleroderma	0.000343	0.00116	CcSEcCtD
Bumetanide—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000325	0.0011	CcSEcCtD
Bumetanide—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000325	0.0011	CcSEcCtD
Bumetanide—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000321	0.00108	CcSEcCtD
Bumetanide—Urticaria—Prednisone—systemic scleroderma	0.000316	0.00106	CcSEcCtD
Bumetanide—Abdominal pain—Prednisone—systemic scleroderma	0.000314	0.00106	CcSEcCtD
Bumetanide—Hypotension—Methotrexate—systemic scleroderma	0.000311	0.00105	CcSEcCtD
Bumetanide—Fatigue—Methotrexate—systemic scleroderma	0.000287	0.000965	CcSEcCtD
Bumetanide—Asthenia—Prednisone—systemic scleroderma	0.000285	0.000961	CcSEcCtD
Bumetanide—Pruritus—Prednisone—systemic scleroderma	0.000281	0.000948	CcSEcCtD
Bumetanide—Diarrhoea—Prednisone—systemic scleroderma	0.000272	0.000917	CcSEcCtD
Bumetanide—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000272	0.000916	CcSEcCtD
Bumetanide—Urticaria—Methotrexate—systemic scleroderma	0.000264	0.000889	CcSEcCtD
Bumetanide—Dizziness—Prednisone—systemic scleroderma	0.000263	0.000886	CcSEcCtD
Bumetanide—Abdominal pain—Methotrexate—systemic scleroderma	0.000263	0.000885	CcSEcCtD
Bumetanide—Vomiting—Prednisone—systemic scleroderma	0.000253	0.000852	CcSEcCtD
Bumetanide—Rash—Prednisone—systemic scleroderma	0.000251	0.000845	CcSEcCtD
Bumetanide—Dermatitis—Prednisone—systemic scleroderma	0.00025	0.000844	CcSEcCtD
Bumetanide—Headache—Prednisone—systemic scleroderma	0.000249	0.000839	CcSEcCtD
Bumetanide—Asthenia—Methotrexate—systemic scleroderma	0.000238	0.000803	CcSEcCtD
Bumetanide—Nausea—Prednisone—systemic scleroderma	0.000236	0.000796	CcSEcCtD
Bumetanide—Pruritus—Methotrexate—systemic scleroderma	0.000235	0.000792	CcSEcCtD
Bumetanide—Diarrhoea—Methotrexate—systemic scleroderma	0.000227	0.000766	CcSEcCtD
Bumetanide—Dizziness—Methotrexate—systemic scleroderma	0.00022	0.00074	CcSEcCtD
Bumetanide—Vomiting—Methotrexate—systemic scleroderma	0.000211	0.000712	CcSEcCtD
Bumetanide—Rash—Methotrexate—systemic scleroderma	0.00021	0.000706	CcSEcCtD
Bumetanide—Dermatitis—Methotrexate—systemic scleroderma	0.000209	0.000705	CcSEcCtD
Bumetanide—Headache—Methotrexate—systemic scleroderma	0.000208	0.000701	CcSEcCtD
Bumetanide—Nausea—Methotrexate—systemic scleroderma	0.000197	0.000665	CcSEcCtD
